HIGH-AFFINITY HUMAN ANTI-PCSK9 ANTIBODIES Russian patent published in 2015 - IPC C07K16/40 C12N15/13 C12N15/63 A61K39/395 A61P3/06 

Abstract RU 2552169 C2

FIELD: medicine.

SUBSTANCE: presented invention refers to immunology. Disclosed are versions of a human antibody or an antigen-binding fragment of the human antibody, which specifically bind and inhibit human proprotein convertase subtilisin/kexin type 9 (hPCSK9). Each version is characterised by the fact that it contains 6 CDRs of heavy and light chains. Described are: an isolated coding nucleic acid, and expression vector and a method for producing the antibody with the use of the above vector. Presented is a pharmaceutical formulation based on the antibody for treating a disease or a condition which can be relieved, improved, suppressed or prevented by means of the anti-PCSK9 antibody.

EFFECT: using the invention provides the new versions of the antibodies able to reduce serum low-density lipoprotein cholesterol accompanied by no considerable changes or no effect on the hepatic function according to measured alanine-aminotransferase and aspartate-aminotransferase.

8 cl, 14 dwg, 28 tbl, 17 ex

Similar patents RU2552169C2

Title Year Author Number
HIGH AFFINITY HUMAN PCSK9 ANTIBODIES 2009
  • Sliman Mark U.
  • Martin Dzhoel Kh.
  • Khuan Tammi T.
  • Makdonald Duglas
RU2697773C2
HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS 2012
  • Anoten Korinn
  • Bessak Lorans
  • Chaudkhari Umesh
RU2603481C2
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES TO HUMAN PCSK9 2012
  • Anoten Korinn
  • Bessak Lorans
  • Chaudkhari Umesh
RU2604139C2
ANTI-ANGPTL3 ANTIBODIES AND THEIR APPLICATION 2012
  • Sliman Mark U.
  • Gusarova Viktoriya
  • Merfi Endryu Dzh.
RU2620064C2
PCSK9 ANTAGONISTS 2009
  • Ljan Khun
  • Abdich Jasmina Noubija
  • Chaparro Riggers Khav'Er
  • Fernando Gomes Brjus Charl'Z
  • Khokinz Dzhuli Dzhija Li
  • Ponz Khaume
  • Tsju Sjajan
  • Strop Pavel
  • Vang Jujli
RU2528735C2
HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING SPECIFIC GROUPS OF INDIVIDUALS 2012
  • Hanotin, Corinne
  • Bessac, Laurence
  • Chaudhari, Umesh
RU2721279C2
PCSK9 ANTAGONISTS 2014
  • Lyan Khun
  • Abdich Yasmina Noubiya
  • Chaparro Riggers Khaver Fernando
  • Gomes Bryus Charlz
  • Khokinz Dzhuli Dzhiya Li
  • Ponz Khaume
  • Tsyu Syayan
  • Strop Pavel
  • Vang Yujli
RU2618869C2
ANTAGONISTS 2019
  • Bredli, Allan
  • Lyan, Tsi
  • Li, E-Chian
  • Liou, Li-In
  • Khuan, Yuj-Khuej
  • Chen, En-Tszyuj
  • Chen, Li-Ttsu
RU2839429C2
ANTIBODIES WITH PH-DEPENDENT ANTIGEN BINDING 2011
  • Pons Dzhom
  • Chehbot Dzheffri Rehjmond
  • Chaparro Ridzhers Khav'Er Fernando
  • Gomes Brjus Charl'Z
  • Ljan Khon
  • Majavala Kapil
  • Mettetal' Vtoroj Dzherom Tomas
  • Radzhpal Arvind
  • Shelton Dehvid L'Juis
RU2570729C2
ANTI-PCSK9 ANTIBODY, ITS ANTIGEN-BINDING DOMAIN AND MEDICAL APPLICATION THEREOF 2016
  • Tsyuj, Syandun
  • E, Sin
  • Syuj, Shaoyu
  • Yuan, Bej
  • Tsuj, Dunbin
  • Khu, Tsiyue
  • Chzhan, Lej
  • Syuj, Chzhibin
  • Tao, Vejkan
  • Chzhan, Lyanshan
  • Sun, Pyaoyan
RU2739208C2

RU 2 552 169 C2

Authors

Sliman, Mark, U.

Martin, Dzhoehl, Kh.

Khuan, Tammi, T.

Makdonald, Duglas

Dates

2015-06-10Published

2009-12-15Filed